Analysts expect Monsanto (NYSE:MON) to post $4.62 billion in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Monsanto’s earnings. The lowest sales estimate is $4.45 billion and the highest is $4.79 billion. Monsanto posted sales of $4.23 billion in the same quarter last year, which suggests a positive year-over-year growth rate of 9.2%. The business is expected to announce its next earnings report on Wednesday, June 27th.
On average, analysts expect that Monsanto will report full year sales of $15.05 billion for the current year, with estimates ranging from $14.67 billion to $15.58 billion. For the next fiscal year, analysts forecast that the company will post sales of $15.81 billion per share, with estimates ranging from $15.36 billion to $16.59 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research analysts that cover Monsanto.
Monsanto (NYSE:MON) last released its quarterly earnings data on Thursday, April 5th. The basic materials company reported $3.22 earnings per share for the quarter, missing analysts’ consensus estimates of $3.31 by ($0.09). The company had revenue of $5.02 billion for the quarter, compared to analysts’ expectations of $5.34 billion. Monsanto had a net margin of 17.07% and a return on equity of 37.31%. The business’s revenue for the quarter was down 1.1% compared to the same quarter last year. During the same period last year, the company posted $3.19 EPS.
A number of analysts have recently weighed in on MON shares. Sanford C. Bernstein reissued a “neutral” rating and set a $119.00 price objective on shares of Monsanto in a research note on Monday, April 9th. Zacks Investment Research lowered Monsanto from a “hold” rating to a “sell” rating in a research note on Monday, April 9th. ValuEngine raised Monsanto from a “hold” rating to a “buy” rating in a research note on Monday, April 9th. Argus lowered Monsanto from a “buy” rating to a “sell” rating in a research note on Monday, April 16th. Finally, BMO Capital Markets lowered Monsanto from an “outperform” rating to a “market perform” rating in a research note on Tuesday, April 10th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $126.61.
A number of hedge funds have recently made changes to their positions in MON. Creative Planning lifted its position in Monsanto by 4.2% during the fourth quarter. Creative Planning now owns 26,559 shares of the basic materials company’s stock valued at $3,102,000 after buying an additional 1,061 shares during the period. Schwab Charles Investment Management Inc. increased its holdings in shares of Monsanto by 3.5% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 1,628,413 shares of the basic materials company’s stock valued at $190,167,000 after acquiring an additional 54,336 shares in the last quarter. State of Alaska Department of Revenue increased its holdings in shares of Monsanto by 41.7% during the fourth quarter. State of Alaska Department of Revenue now owns 161,990 shares of the basic materials company’s stock valued at $18,915,000 after acquiring an additional 47,698 shares in the last quarter. Personal Capital Advisors Corp increased its holdings in shares of Monsanto by 9.8% during the fourth quarter. Personal Capital Advisors Corp now owns 202,371 shares of the basic materials company’s stock valued at $23,633,000 after acquiring an additional 18,004 shares in the last quarter. Finally, Omni Partners LLP bought a new position in shares of Monsanto during the fourth quarter valued at $6,396,000. 74.85% of the stock is owned by institutional investors.
Shares of NYSE:MON traded up $0.02 during trading on Friday, reaching $125.85. 89,163 shares of the company traded hands, compared to its average volume of 3,651,318. The firm has a market cap of $55.47 billion, a PE ratio of 22.89, a price-to-earnings-growth ratio of 2.60 and a beta of 0.95. Monsanto has a 52-week low of $114.19 and a 52-week high of $126.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.85 and a current ratio of 1.41.
Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.